BriaCell Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lynwood Opportunities Master Fund(9.3%),Lynwood Capital Management Inc.(9.3%), etc.
Feb 14, 2023 16:35 ET
BriaCell Therapeutics | 4: Statement of changes in beneficial ownership of securities
Dec 28, 2022 16:38 ET
BriaCell Therapeutics | 4: Statement of changes in beneficial ownership of securities
Dec 28, 2022 15:22 ET
BriaCell Therapeutics | 4: Statement of changes in beneficial ownership of securities
Dec 20, 2022 21:02 ET
BriaCell Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Bondarenko Jamieson
Aug 11, 2022 17:42 ET
BriaCell Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Lustig Marc
Aug 2, 2022 16:07 ET
BriaCell Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Del Priore Giuseppe
Aug 1, 2022 16:10 ET
BriaCell Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Taub Rebecca
Aug 1, 2022 16:10 ET
BriaCell Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Lopez-Lago Miguel A.
Aug 1, 2022 16:10 ET
BriaCell Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Schmieg Martin E.
Aug 1, 2022 16:10 ET
BriaCell Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Embro-Pantalony Vaughn C.
Aug 1, 2022 16:10 ET
BriaCell Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Williams Williams V.
Aug 1, 2022 16:10 ET
BriaCell Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Gross Jane A
Aug 1, 2022 16:10 ET
BriaCell Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer LEVIN GADI
Aug 1, 2022 16:10 ET
BriaCell Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals
Aug 1, 2022 07:00 ET
BriaCell Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Southwest Private Capital Inc.(5.1%)
Apr 25, 2022 16:05 ET
BriaCell Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-CVI Investments, Inc.(3.6%),Heights Capital Management, Inc.(3.6%)
Feb 14, 2022 15:21 ET
BriaCell Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Altium Capital Management, LP EIN:(4.7%),Altium Growth Fund, LP EIN:(4.7%), etc.
Feb 11, 2022 20:39 ET
BriaCell Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-L1 Capital Global Opportunities Master Fund Ltd.(*%)
Feb 11, 2022 17:47 ET
BriaCell Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lind Global Macro Fund, LP(0.2%),Lind Global Partners LLC(0.2%), etc.
Feb 11, 2022 17:01 ET
No Data
No Data